A study conducted by Katsuno et al. found that upon TGF-β removal, mesenchymal cells revert to an epithelial cell phenotype.200 Moreover, prolonged TGF-β exposure promotes a stable EMT process in cancer cells, which is accompanied by increased tumor stemness and cancer drug resistance. The gene discussed is TGFB1; the disease is cancer.